Home › Hereditary Sensory and Autonomic Neuropathies › Colorado › Denver
Hereditary Sensory and Autonomic Neuropathies clinical trials in Denver, CO
3 studies for Hereditary Sensory and Autonomic Neuropathies are looking for participants at sites in and around Denver (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of ACR-2316 in Specific Advanced Solid Tumors
RecruitingPhase 1/2
- Denver Health One, Denver
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Rocky Mountain Cancer Center, Denver
- Sarah Cannon Research Institute at HealthONE, Denver
Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
RecruitingObservational study
- Rocky Mountain Cancer Centers, Denver
Hereditary Sensory and Autonomic Neuropathies trials in other cities
- San Antonio, TX7 studies
- Arlington, VA7 studies
- New York City, NY6 studies
- Boston, MA6 studies
- Nashville, TN6 studies
- Houston, TX5 studies
- Philadelphia, PA5 studies
- Portland, OR4 studies
- Pittsburgh, PA4 studies
- Ann Arbor, MI4 studies
- Washington, DC4 studies
- Aurora, CO3 studies
Other studies in Denver
- Metastatic Cancer29 studies
- Breast Cancer29 studies
- Non-Small Cell Lung Cancer27 studies
- Multiple Myeloma27 studies
- Colorectal Cancer23 studies
- Melanoma19 studies
- Prostate Cancer19 studies
- Cancer (all types)18 studies
- Ovarian Cancer16 studies
- Lung Cancer16 studies
- Endometrial Cancer15 studies
- Non-Hodgkin Lymphoma14 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.